Voquenza Information Not Available in Provided Evidence
I cannot provide dosing information for "Voquenza 10mg" as this medication does not appear in any of the provided evidence sources. The evidence provided contains information about:
Possible Scenarios
If "Voquenza" is a brand name for an existing antiviral:
- No medication by this name appears in ACIP guidelines or FDA-approved influenza treatments from 2000-2024 1
- This may be a regional brand name, misspelling, or investigational drug not covered in the provided evidence
If you meant a different medication:
- For oseltamivir (Tamiflu): 75 mg twice daily for adults for treatment 1
- For zanamivir (Relenza): 10 mg (2 inhalations) twice daily for treatment 1
- For peramivir: 300-600 mg single IV dose studied in clinical trials 2, 6
To provide accurate dosing information, please verify:
- The correct spelling of the medication name
- Whether this is a brand name used in a specific country
- The generic name of the active ingredient